Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tuesday 4 Feb 2020 is World Cancer Day (https://www.worldcancerday.org/). Led by the Union for International Cancer Control, the day aims to raise awareness and education about cancer.


MaggiesCentreOx2.jpg

The Department of Oncology teamed-up with The Oxford Maggie’s Centre to mark the day with a ‘Science on the Sofa’ chat about Immunotherapy. 

 

We met a group of health professionals and patients from the Churchill Hospital to talk about the science behind immunotherapy and explore how the Department of Oncology is contributing to making immunotherapy more effective and deliver on the promise of this amazing new science.

 

It was a real privilege meet people who have cancer and the people who treat and support them.  The Maggie’s Centre is a beautiful place with all of the comforting calm of the treehouse it closely resembles. 

 

Thank you Claire Marriot for helping create this opportunity.

 

MaggiesOxLogo.png

 

Similar stories

The Department represented at the European Radiation Research Society annual conference

Researchers from the Department of Oncology attend the prestigious European Radiation Research Society (ERRS) in annual conference in Catania, Italy to present their research in Radiation Oncology.

Funding to research metformin’s ability to delay or prevent cancers driven by the mutated TP53 gene

A research project embedded within the Metformin in Li Fraumeni (MILI) trial will investigate metformin’s mechanism of action when taken as a preventative for mTP53-driven cancers.

Cancer patients remain at higher risk of severe COVID-19 disease despite third dose booster vaccine

A large population-level assessment reveals third dose COVID-19 vaccination is effective for most patients with cancer, but effectiveness is lower than in the general population, particularly in patients who have undergone recent chemotherapy and those with lymphoma.

Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis

Body mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

OUH agrees long COVID research collaboration with Polarean

The collaboration will look at understanding the long-term effects of COVID-19 through cutting-edge MRI analysis.